Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight
Document Type
Article
Abstract
Impella is a catheter-based micro-axial flow pump placed across the aortic valve, and it is currently the only percutaneous left ventricular assist device approved for high-risk percutaneous coronary intervention and cardiogenic shock. Areas Covered: Even though several studies have repeatedly demonstrated the excellent hemodynamic profile of Impella in high-risk settings, it remains underutilized. Here we aim to provide an up-to-date summary of the available literature on Impellas use in High risk settings as well as the practical aspects of its usage. Expert Commentary: Percutaneous coronary interventions in high rsk settings have always been challenging for a physician. Impella 2.5 and CP, have been proven safe, cost effective and feasible in High Risk Percutaneous coronary Interventions with an excellent hemodynamic profile.
Medical Subject Headings
Contraindications, Procedure; Cost-Benefit Analysis; Heart-Assist Devices (adverse effects); Hemodynamics; Humans; Medical Illustration; Percutaneous Coronary Intervention (instrumentation, methods); Shock, Cardiogenic (therapy)
Publication Date
10-1-2017
Publication Title
Expert review of medical devices
E-ISSN
1745-2422
Volume
14
Issue
10
First Page
789
Last Page
804
PubMed ID
28862481
Digital Object Identifier (DOI)
10.1080/17434440.2017.1374849
Recommended Citation
Nalluri, Nikhil; Patel, Nileshkumar; Saouma, Samer; Anugu, Viswajit Reddy; Anugula, Dixitha; Asti, Deepak; Mehta, Varshil; Kumar, Varun; Atti, Varunsiri; Edla, Sushruth; Grewal, Rasleen K.; Khan, Hafiz M.; Kanotra, Ritesh; Maniatis, Gregory; Kandov, Ruben; Lafferty, James C.; Dyal, Michael; Alfonso, Carlos E.; and Cohen, Mauricio G., "Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight" (2017). Neurology. 2094.
https://scholar.barrowneuro.org/neurology/2094